Resource library

The Senior Project Officer is responsible for leading the Commission’s Antimicrobial Stewardship (AMS) program work. This includes the development of resources to support AMS, as well as contributing to broader activities to support AURA and IPC/HAI programs. For example, undertaking research and analysis of data and information, project management, policy development and guidance, stakeholder management, facilitation of meetings, preparation of project documentation and collaborating with other relevant programs within the Commission.

-

The Senior Project Officer will be responsible for leading the work on the assigned work plan deliverables and the development of resources for primary care or pathology as required as well as contributing to broader activities to support the National Standards Program. This will include undertaking research and analysis of information, project management, policy development, stakeholder management, facilitation of meetings, preparation of project documentation and collaborating with other relevant programs within the Commission.

This resource provides information about antibiotic shortages for Aboriginal and Torres Strait Islander consumers.

This resource provides general information for health professionals working in Aboriginal Medical Services or Aboriginal Community Controlled Health Organisations. There is also a fact sheet for consumers.

AURA 2023: Fifth Australian Report on Antimicrobial Use and Resistance in Human Health is being released on 16 November 2023, highlighting data trends and analyses across acute and community care settings. 

This Key Findings summary features the most compelling data findings from AURA 2023, with excerpts taken from the report for easy reference.

Australians are unwittingly being exposed to increased risk of harm from taking antibiotics, when often these medicines are used to treat common infections where they will have no or little benefit, according to the Australian Commission on Safety and Quality in Health Care.

Released 16 November 2023

This resource outlines what antimicrobial resistance (AMR) is, and how we need to limit our use of antimicrobials – such as antibiotics, antivirals, antifungals and antiparasitics – to reduce the risk of drug-resistant infections and impact of AMR.

It also outlines potential patient harms to the individual and the broader community from antimicrobial use and resistance. This resource supports the release of AURA 2023: Fifth Australian Report on Antimicrobial Use and Resistance in Human Health on 16 November 2023.

AURA 2023: Fifth Australian Report on Antimicrobial Use and Resistance in Human Health was released on 16 November 2023, highlighting data trends and analyses across acute and community care settings. 

This A4 infographic showcases key data highlights from AURA 2023 on antimicrobial use in Australia.

This bimonthly data update provides data submitted to CARAlert for the reporting period 1 July to 31 August 2023. These data can be used to inform, and support, the prevention and control of antimicrobial resistance.

This fact sheet provides information for consumers about antibiotic use and antibiotic resistance. It is designed to help clinicians and consumers answer the question, Do I really need antibiotics?

This fact sheet highlights key findings from AURA 2023 and priorities for action to support primary care services and clinicians prevent and control antimicrobial resistance (AMR) and improve antimicrobial use.

This fact sheet highlights key findings from AURA 2023 and information about antimicrobial stewardship (AMS) and antimicrobial resistance (AMR), to support pharmacists working across primary and acute care settings.

This fact sheet highlights key findings from AURA 2023 and priorities for action to support infection prevention and control clinicians prevent and control antimicrobial resistance (AMR) and improve antimicrobial use.

This fact sheet highlights key findings from AURA 2023 and priorities for action to support aged care services and clinicians prevent and control antimicrobial resistance (AMR) and improve antimicrobial use.

This fact sheet highlights key conclusions and priorities for action identified in AURA 2023 to prevent and control antimicrobial resistance (AMR) and improve antimicrobial use.

This report provides supplementary data to Chapter 4 of AURA 2023: Fifth Australian report on antimicrobial use and resistance in human health.

AURA 2023 includes data and analyses from 2020–2022 (primarily 2020–2021) from various sources and reports on patterns and trends in antimicrobial use and appropriateness and antimicrobial resistance (AMR) in Australian acute and community healthcare settings.

The 2023 APS employee census was undertaken between 8 May 2023 and 9 June 2023.

As part of our commitment to making the Commission an even better place to work, we have implemented an agency-wide action plan to address areas where we can improve.

The Australian Commission on Safety and Quality in Health Care (the Commission) is hosting the National Medicines Symposium 2023 (the Symposium) on Wednesday 8 November.

Released 30 October 2023

The Annual Report 2022-23 provides an overview of our performance, governance arrangements, organisational structure and financial statements for the past financial year.

Service providers implementing the Digital Mental Health Standards are required to have a clearly described model of care consistent with best practice and evidence. This fact sheet describes the key elements that should be included.

The Commission is undertaking a public consultation on the COPD Clinical Care Standard from 6 November to 18 December 2023. The consultation questions are available to review in PDF format.

This document describes each of the quality statements in the draft Chronic Obstructive Pulmonary Disease (COPD) Clinical Care Standard, and what they mean for consumers.

The Commission is undertaking a public consultation on the COPD Clinical Care Standard from 6 November to 18 December 2023. We welcome comments on the draft Standard and this Guide for consumers. 

The Chronic Obstructive Pulmonary Disease (COPD) Clinical Care Standard consultation draft contains 10 quality statements and a set of indicators to support the key aspects of care relating to the diagnosis and management of COPD, including exacerbations.

Each quality statement is explained for consumers, clinicians, and healthcare services.

The Commission is undertaking a public consultation on the COPD Clinical Care Standard from 6 November to 18 December 2023. We welcome comments on the draft Standard.

This guide provides instructions for National Hand Hygiene Initiative (NHHI) Learning Management System (LMS) Region Administrators on how to:

• Check their learners’ progress in the hand hygiene auditor training pathways 
• Enrol them in the relevant modules, training pathways and assessments.

This guide provides instructions for National Hand Hygiene Initiative (NHHI) Learning Management System (LMS) Organisation Administrators on how to:

• Check their learners’ progress in the hand hygiene auditor training pathways 
• Enrol them in the relevant modules, training pathways and assessments.

This quick guide outlines the care described in the Low Back Pain Clinical Care Standard for patients presenting to their chiropractor for a new acute episode of low back pain, with or without leg pain.

This tool is designed to be used as a guide for developing and recording a training session, using the resources from NHHI’s LMS eLearning module The Basics of Infection Prevention and Control: Train the Trainer module and your own experience.